Results: Of the 13 breast carcinoma cases, there were invasive ductal carcinoma (IDC) (n=5), invasive lobular carcinoma (ILC) (n=5), pleomorphic lobular carcinoma (PLC) (n=1), and mucinous carcinoma (MC) (n=2). 3 cases of IDC, 1 cases of PLC, and 1 case of MC had grade 2 or 3 nuclear atypia, whereas 1 case of IDC, 4 cases of ILC, and 1 case of MC had grade 1 nuclear atypia. Axillary lymph nodes were positive for metastatic carcinoma in 1 case with IDC and 1 case with ILC. In fine needle aspiration smears, the intracytoplasmic lumen (ICL) type SRCs were found to be major constituents of SRCs in ILC and PLC, while non-ICL type SRCs were predominant in IDC. MC tumors had SRCs of both ICL and non-ICL types. During our follow-up period ranging from 97 to 3650 (1458 ± 1055) days, all the patients were alive without recurrence of the tumor.
INTRODUCTION
Signet ring cell (SRC) carcinoma is a unique subtype of mucin-producing adenocarcinoma arising in various organs such as the stomach, colon, lungs, and prostate gland (1) (2) (3) (4) . The presence of SRCs in breast cancer was first reported by Saphir more than half a century ago (5). Steinbrecher et al. described 5 cases of SRC type of breast cancer as an uncommon type of breast cancer characterized by the presence of intracellular mucin cells without large amounts of extra-cellular mucin (6) . Hull et al. later found that SRC type of breast cancer were extremely rare, which were only comprised about 4.5% of all the breast cancers (7) (8) (9) . In 2012, World Health Organization has included a section on 'carcinomas with SRC differentiation' in the chapter on mucinous carcinoma (MC); however, it remains undetermined whether breast cancer with SRCs should represent a distinct disease entity (10) .
Histological characteristics of breast carcinoma with SRCs have been elusive because of the conflicting results from earlier studies. Some studies have demonstrated that breast cancers with SRCs are generally invasive lobular carcinomas (ILC) (11) (12) . However, Kelten et al. has reported 10 cases of SRCs type of breast cancer, about which 7 cases were invasive ductal carcinoma (IDC), 2 cases were ILC, and the remaining was a mixture of IDC and ILC (13) . Other studies have found that the presence of SRCs has the similar frequency in IDC and ILC (14) (15) .
Regardless of the origin, breast cancer with SRCs behaves more aggressively than other breast cancers without SRCs (7, (11) (12) . Therefore, it is crucial to identify the presence of SRCs during histological diagnosis of breast cancers. Accordingly, it is important to recognize SRCs in fine needle aspiration (FNA) cytology smears as well, which is usually performed prior to surgical resection of the breast tumor.
In the present study, we investigated the clinicopathological features of breast carcinomas with SRCs. The SRCs were classified into intracytoplasmic lumen (ICL) type and non-ICL type according to the definition described previously (10, 16) . We also retrospectively reviewed FNA findings of each case to describe cytomorpholoigcal characteristics of breast carcinoma with SRCs.
SUBJECTS AND METHODS

Case selection
We searched the archives at the Department of Diagnostic Pathology, Shandong University (China) between January 2006 and August 2015. We found 29 cases with "SRC" in the diagnostic lines and/or histological description. Patients with breast cancer metastasized from primary carcinomas to the distant organs were excluded. We chose 13 cases that had undergone FNA cytology examination before excisional biopsy or operation. We reviewed all the histological sections of each case to confirm that at least 20% of the tumor cells consisted of SRCs,based on a previous report that stated that the presence of SRCs accounting for more than 20% of the tumor should have clinical significance (11) .
FNA cytology was performed by a number of experienced surgeons by using a 20-gauge needle attached to a 20 mL syringe. Clinical data were extracted and reviewed from medical charts and pathology reports. This study was conducted in accordance with the principles embodied in the Declaration of Helsinki and informed consent was obtained from each patient for the use of their tissues samples.
Special and immunohistochemical stainings
Specimens were smeared on glass slides and immediately fixed with solution containing 95% ethanol. Subsequently, the cytological slides were stained according to the routine Papanicolaou method. Formalin-fixed histological sections of the tumors were stained with alcian blue (AB) (pH 2.5) and periodic acid-Schiff (PAS) to reveal both acidic (blue) and neutral (red) mucins (17) .
Immunohistochemical staining was performed with primary antibodies by using the standard avidin-biotin-peroxidase complex technique. The following antibodies were used: E-cadherin 
Review of FNA cytology smears
We examined FNA smears to assess the morphological features of SRCs. An SRC was defined as a cell with a single large vacuole within the cytoplasm. We further classified SRCs into ICL type and non-ICL type based on the definition described previously (10, 16) . Specifically, ICL type SRCs are characterized by a "target" appearance owing to the presence of a large ICL containing PAS or AB positive globules. Non-ICL type SRCs contain acidic muco-substance that diffusely fills the cytoplasm and dislodges the nucleus to one pole of the cell, as seen in gastric carcinoma. as mild: less than 2 × RBC, moderate: 2-3 × RBC, and large: greater than 3 × RBC as described elsewhere (20) . A review of the cytological diagnosis and cytohistological spe-cimens was performed by two pathologists (R.O and T.S). Table 1 summarizes patient and tumor characteristics of 13 patients of SRC type of breast cancer.
RESULTS
Clinicopathological profiles of breast carcinoma with SRCs
The diagnosis of lobular carcinoma was confirmed by detecting the loss of E-cadherin expression. Review of FNA cytology reports and detailed characteristics of FNA smears Table 3 summarizes cytological findings of the FNA smears. ICL type SRCs were seen in all the ILC and PLC cases, and in 2 of the 5 IDC cases (Figure 2A-E) . Non-ICL type SRCs were present in 3 IDC cases, but were identified in only 1 ILC case, and were absent in the PLC case ( Figure   2B , 2F). MC cases had both ICL and non-ICL type SRCs. These findings suggest that ICL type SRCs are more commonly seen in ILC than in IDC, consistent with the findings of a previous report (16) . All the patients showed moderate or high degree of cellularity, except for one patient with IDC who showed low cellularity. given that IDC and ILC account for 80% and 15%, respectively, of the breast carcinomas treated at our institution, it is difficult to estimate the percentage of SRCs contained in ILC and IDC.
A notable finding in our study is the case of PLC with SRCs. The PLC was first described by Dixon et al (22) . It exhibits the infiltrating patterns of classic ILC with pleomorphic nuclei and often shows aggregation of tumor cells. Compared with the FNA smears of conventional ILC, those of PLC are more cellular, with 2 or 3 times larger nuclei, showing irregular contours, prominent nucleoli, hyperchromasia, and high mitotic activity (23) (24) (25) . These cytological features often overlap with those of IDC, resulting in erroneous diagnoses (26) . Clinically, patients with PLC tend to have a poor prognosis, explained by the advanced stage at presentation, and they are more likely to develop distant metastasis and recurrence than those with the classical form of ILC (27) (28) . In our case of PLC, irregular contours, prominent nucleoli, and hyperchromasia were noted, as reported previously. In addition to these features, our PLC case presented with SRCs. To our knowledge, there are only a few reports of the presence of SRCs in PLC; thus, the presence of SRCs in PLC remains under-recognized (29) (30) . Our study indicates that PLC should be included in the differential diagnoses when SRCs are identified in FNA smears.
Regardless of the primary organs affected, carcinomas with SRCs tend to have an aggressive clinical course due to frequent metastasis to lymph nodes (1-4) . However, the prognosis of breast carcinoma with SRCs varies depending on the study, probably because the diagnostic criteria for SRC carcinoma have not been strictly defined. Merino et al demonstrated that ILC in which SRCs account for more than 20% of the tumor cells showed a poor prognosis: 60% of the patients died within 7 years, and some of them exhibited unusual metastatic pattern, with a propensity to involve serosal surfaces of gastrointestinal tracts (11).
Frost et al showed that the presence of 10% or more SRCs represents a poor individual prognostic factor in patients with ILC due to frequent recurrence or distant metastasis (21) . In our study, only 2 of the 11 patients evaluated showed lymph node metastasis even though SRCs accounted for more than 20% of tumor cells in all the patients. Based on our results, we are unable to conclude that the presence of SRCs could be an adverse prognostic factor for breast cancer. A study evaluating a higher number of SRC cases, with a longer follow-up period, is needed to determine the clinical significance of SRCs in breast cancer.
In our study, 2 cases exhibited histological features of MC. One may argue that these cases should not be considered as carcinoma with SRCs, as some studies have suggested that carcinoma with SRCs should be distinguished from MC (6, 31) . In contrast, Kuroda et al propose that there should be a distinct type of MC characterized by the presence of SRCs, apart from MC lacking the presence of SRCs (32) . Although it remains controversial how these cases should be categorized, further studies using a larger number of similar cases with correlations to clinical profiles are needed to clarify the clinical significance of SRCs in MC. 
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